Prevalent vertebral fractures predict hospitalization and mortality in older women: The fracture intervention trial (FIT).

被引：0
|
作者：
Ensrud, K
Thompson, D
Nevitt, M
Hochberg, M
Santora, A
Black, DM
机构：
[1] Univ Minnesota, FIT Res Grp, Minneapolis, MN 55455 USA
[2] Univ Calif San Francisco, FIT Res Grp, San Francisco, CA 94143 USA
[3] Univ Maryland, FIT Res Grp, College Pk, MD 20742 USA
[4] Merck Res Labs, Rahway, NJ USA
来源：
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE | 1999年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：709 / 709
页数：1
相关论文
共 50 条
  • [31] Does alendronate reduce the risk of non-vertebral fracture in women without vertebral fracture who have osteopenia and a history of non-vertebral fracture? The Fracture Intervention Trial (FIT).
    Ryder, KM
    Bauer, DC
    Bush, AJ
    Satterfield, S
    Palermo, L
    Schwartz, A
    Feldstein, A
    Ensrud, K
    Cummings, SR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S397 - S397
  • [32] The Burden of Prevalent Vertebral Fractures is Negatively Associated with Functional Outcome in Women with Hip Fracture
    Di Monaco, Marco
    Vallero, Fulvia
    Di Monaco, Roberto
    Franza, Gianluca
    Tappero, Rosa
    [J]. AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2011, 90 (01) : 1 - 7
  • [33] Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial
    Katzman, W. B.
    Vittinghoff, E.
    Kado, D. M.
    Lane, N. E.
    Ensrud, K. E.
    Shipp, K.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 (03) : 899 - 903
  • [34] Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial
    W. B. Katzman
    E. Vittinghoff
    D. M. Kado
    N. E. Lane
    K. E. Ensrud
    K. Shipp
    [J]. Osteoporosis International, 2016, 27 : 899 - 903
  • [35] Reliability of vertebral fracture assessment to predict vertebral fractures
    Chavrimootoo, S.
    O'Regan, K.
    Daly, M.
    Harney, S.
    Maher, M.
    Molloy, M. G.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : 76 - 77
  • [36] Risedronate rapidly and consistently reduces risk of further vertebral fracture in women with multiple prevalent vertebral fractures.
    Brown, JP
    Hosking, D
    Josse, R
    Johnell, O
    Leib, E
    Roux, C
    Stracke, H
    Bos, K
    Horlait, S
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S150 - S150
  • [37] Raloxifene reduces the clinical vertebral fracture risk at 1 year in women with osteoporosis without prevalent vertebral fractures
    Qu, Y
    Stock, JL
    Thiebaud, D
    Wong, M
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 809 - 809
  • [38] Incident vertebral fractures and mortality in older women: A prospective study.
    Kado, DM
    Duong, T
    Stone, KL
    Ensrud, KE
    Nevitt, MC
    Hochberg, MC
    Greendale, GA
    Cummings, SR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S214 - S214
  • [39] Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial
    Hagino, Hiroshi
    Shiraki, Masataka
    Fukunaga, Masao
    Nakano, Tetsuo
    Takaoka, Kunio
    Ohashi, Yasuo
    Nakamura, Toshitaka
    Matsumoto, Toshio
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2013, 31 (05) : 544 - 550
  • [40] Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial
    Hiroshi Hagino
    Masataka Shiraki
    Masao Fukunaga
    Tetsuo Nakano
    Kunio Takaoka
    Yasuo Ohashi
    Toshitaka Nakamura
    Toshio Matsumoto
    [J]. Journal of Bone and Mineral Metabolism, 2013, 31 : 544 - 550
12345